116 related articles for article (PubMed ID: 10935476)
1. Loss of immunoreactivity for human calmodulin-like protein is an early event in breast cancer development.
Rogers MS; Foley MA; Crotty TB; Hartmann LC; Ingle JN; Roche PC; Strehler EE
Neoplasia; 1999 Aug; 1(3):220-5. PubMed ID: 10935476
[TBL] [Abstract][Full Text] [Related]
2. Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation.
Brooks MD; Bennett RD; Strehler EE; Sebo TJ; Eckert SE; Carr AB
J Prosthodont; 2009 Jan; 18(1):11-6. PubMed ID: 19166543
[TBL] [Abstract][Full Text] [Related]
3. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
4. Human calmodulin-like protein is an epithelial-specific protein regulated during keratinocyte differentiation.
Rogers MS; Kobayashi T; Pittelkow MR; Strehler EE
Exp Cell Res; 2001 Jul; 267(2):216-24. PubMed ID: 11426940
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin-like protein increases filopodia-dependent cell motility via up-regulation of myosin-10.
Bennett RD; Mauer AS; Strehler EE
J Biol Chem; 2007 Feb; 282(5):3205-12. PubMed ID: 17130134
[TBL] [Abstract][Full Text] [Related]
6. Protein product of a human intronless calmodulin-like gene shows tissue-specific expression and reduced abundance in transformed cells.
Yaswen P; Smoll A; Hosoda J; Parry G; Stampfer MR
Cell Growth Differ; 1992 Jun; 3(6):335-45. PubMed ID: 1419896
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical demonstration of calmodulin and its activated forms in normal and carcinomatous human mammary tissue.
Tuccari G; Rizzo A; Barresi G
Eur J Histochem; 1993; 37(1):59-64. PubMed ID: 7682869
[TBL] [Abstract][Full Text] [Related]
8. bcl-2 expression in the spectrum of preinvasive breast lesions.
Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
[TBL] [Abstract][Full Text] [Related]
9. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
10. KAI1 protein is down-regulated during the progression of human breast cancer.
Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
[TBL] [Abstract][Full Text] [Related]
11. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities.
Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX
Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258
[TBL] [Abstract][Full Text] [Related]
12. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
13. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.
Clezardin P; Frappart L; Clerget M; Pechoux C; Delmas PD
Cancer Res; 1993 Mar; 53(6):1421-30. PubMed ID: 7680285
[TBL] [Abstract][Full Text] [Related]
14. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
15. Interferon regulatory factor expression in human breast cancer.
Doherty GM; Boucher L; Sorenson K; Lowney J
Ann Surg; 2001 May; 233(5):623-9. PubMed ID: 11323500
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells.
Yaswen P; Smoll A; Peehl DM; Trask DK; Sager R; Stampfer MR
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7360-4. PubMed ID: 2217169
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin-like protein upregulates myosin-10 in human keratinocytes and is regulated during epidermal wound healing in vivo.
Bennett RD; Mauer AS; Pittelkow MR; Strehler EE
J Invest Dermatol; 2009 Mar; 129(3):765-9. PubMed ID: 18818677
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
19. Hormones and progeny of breast tumor cells.
Schneider HP; Böcker W
Climacteric; 2006 Apr; 9(2):88-107. PubMed ID: 16698656
[TBL] [Abstract][Full Text] [Related]
20. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland.
Hombach-Klonisch S; Buchmann J; Sarun S; Fischer B; Klonisch T
Cancer; 2000 Dec; 89(11):2161-8. PubMed ID: 11147585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
